Literature DB >> 26219235

Plasmodium vivax: a roadblock on the quest to eliminate malaria.

Richard Cibulskis1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26219235     DOI: 10.1016/S1473-3099(15)00237-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

1.  Genetic Spatiotemporal Anatomy of Plasmodium vivax Malaria Episodes in Greece, 2009-2013.

Authors:  Gregory Spanakos; Georges Snounou; Danai Pervanidou; Michael Alifrangis; Anna Rosanas-Urgell; Agoritsa Baka; Maria Tseroni; Annita Vakali; Evdokia Vassalou; Eleni Patsoula; Herve Zeller; Wim Van Bortel; Christos Hadjichristodoulou
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

2.  Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Authors:  Rachael Milligan; André Daher; Patricia M Graves
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

3.  Transition of radical, preventive and presumptive treatment regimens for malaria in China: a systematic review.

Authors:  Jian-Wei Xu; Rogan Lee; Xiao-Hong Li; Hui Liu
Journal:  Malar J       Date:  2021-01-06       Impact factor: 2.979

4.  Care-seeking delay of imported malaria to China: implications for improving post-travel healthcare for migrant workers.

Authors:  Guangyu Lu; Yuanyuan Cao; Qi Chen; Guoding Zhu; Olaf Müller; Jun Cao
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

5.  Challenges in and lessons learned during the implementation of the 1-3-7 malaria surveillance and response strategy in China: a qualitative study.

Authors:  Guangyu Lu; Yaobao Liu; Claudia Beiersmann; Yu Feng; Jun Cao; Olaf Müller
Journal:  Infect Dis Poverty       Date:  2016-10-05       Impact factor: 4.520

6.  Malaria burden and treatment targets in Kachin Special Region II, Myanmar from 2008 to 2016: A retrospective analysis.

Authors:  Hui Liu; Jian-Wei Xu; Yaw Bi
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.